Table 4 IHL subsets in donors
IHL subsets | %Mean±s.d. (range) (n=19) |
|---|---|
CD3 + population | |
CD4+CD3+ | 29.6±7.6 (23–47.4) |
CD8+CD3+ | 43.9±8.5 (37.9–61.8) |
CD4+CD8+ | 2.7±3.4 (0.3–10.5) |
CD4−CD8− | 22.7± (9.8–38.6) |
CD4+: CD8+ | 0.7±0.2 (0.5–1.3) |
αβTCR | 80.8±10.3 (58.4–92.9) |
γδTCR | 18.8±12.9 (3.1–42.8) |
CD3+CD56− | 76.9±8.6 (62.4–87.8) |
CD3+CD56+ | 23.1±8.6 (12.2–37.7) |
CD3+CD161+CD56+ | 15.9±5.9 (8.4–26) |
CD3+Vα24+ | 1.3±0.8 (1.2–2.5) |
CD4 + population | |
CD4+CD8+ | 10.2±9.7 (2.7–30.5) |
αβTCR | 81.7±7.1 (70.4–93.8) |
γδTCR | 15.9±11 (1.01–30.1) |
CD45RO+ | 66±11 (38.4–73) |
CD8 + population | |
CD8+CD4+ | 6.7±5.9 (1.4–18.8) |
αβTCR | 83.7±6.6 (69.1–91.1) |
γδTCR | 18.4±14.1 (2.1–39.4) |
CD45RO+ | 35.2±20.9 (9.6–60) |
